Enhanced expression of the ubiquitin-proteasome system in the myocardium from patients with dilated cardiomyopathy referred for left ventriculoplasty: An immunohistochemical study with special reference to oxidative stress

Heart and Vessels

Volumn 25, Issue 6, 2010, Pages 474-484

  Otsuka, Koji ^a   Terasaki, Fumio ^a   Shimomura, Hiroaki ^a   Tsukada, Bin ^a   Horii, Taiko ^b   Isomura, Tadashi ^c   Suma, Hisayoshi ^d   Shibayama, Yuro ^a   Kitaura, Yasushi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c Hayama Heart Center   (Japan)

^d THE CARDIOVASCULAR INSTITUTE   (Japan)

Author keywords

Dilated cardiomyopathy; Immunohistochemistry; Oxidative stress; Ubiquitin proteasome system

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BRAIN NATRIURETIC PEPTIDE; CYTOTOXIC FACTOR; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MEMBRANE PROTEIN; OXIDATION INDUCED MODIFIER MOLECULE; PROTEASOME; UBIQUITIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONGESTIVE CARDIOMYOPATHY; CORRELATION ANALYSIS; FEMALE; HEART MUSCLE; HEART MUSCLE CELL; HEART SURGERY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE FIBRIL; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PATIENT REFERRAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; VENTRICULOPLASTY;

ADULT; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; MALE; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; REFERRAL AND CONSULTATION; UBIQUITIN; UP-REGULATION;

EID: 78549285972     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-010-0006-3     Document Type: Article

References (32)

1. RD Klausner R Sitia 1990 Protein degradation in the endoplasmic reticulum Cell 62 611 614 1:CAS:528:DyaK3cXlvVKlt7g%3D 10.1016/0092-8674(90)90104-M 2201450 (Pubitemid 20275702)
2. A Hershko A Ciechanover A Varshavsky 2000 Basic medical award. The ubiquitin system Nat Med 6 1073 1081 1:CAS:528:DC%2BD3cXntlKns7o%3D 10.1038/80384 11017125
3. AM Weissman 2001 Themes and variations on ubiquitylation Nat Rev Mol Cell Biol 2 169 178 1:CAS:528:DC%2BD3MXhvFKrs74%3D 10.1038/35056563 11265246 (Pubitemid 33675741)
4. Y Ohsumi 2001 Molecular dissection of autophagy: two ubiquitin-like system Nat Rev Mol Cell Biol 2 211 216 1:CAS:528:DC%2BD3MXhvFyjtr8%3D 10.1038/35056522 11265251 (Pubitemid 33675746)
5. CW Wang DJ Klionsky 2003 The molecular mechanism of autophagy Mol Med 9 65 76 12865942
6. ER Stadtman 1992 Protein oxidation and aging Science 257 1220 1224 1:CAS:528:DyaK38Xls1yitrk%3D 10.1126/science.1355616 1355616
7. M Bucciantini E Giannoni F Chiti F Broni L Formiqli J Zurdo N Taddei G Ramponi CM Dobson M Stefani 2002 Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases Nature 416 483 484 10.1038/416507a (Pubitemid 34288846)
8. JJ Belch AB Bridges N Scott M Chopra 1991 Oxygen free radicals and congestive heart failure Br Heart J 65 245 248 1:STN:280:DyaK3M3kvVGksQ%3D%3D 10.1136/hrt.65.5.245 2039668
9. J Weekes K Morrison A Mullen R Wait P Barton MJ Dunn 2003 Hyperubiquitination of protein in dilated cardiomyopathy Proteomics 3 208 216 1:CAS:528:DC%2BD3sXhvVOltbw%3D 10.1002/pmic.200390029 12601813 (Pubitemid 36254603)
10. H Shimomura F Terasaki T Hayashi Y Kitaura T Isomura T Suma 2001 Autophagic degeneration as a possible mechanism of myocardial cell death in dilated cardiomyopathy Jpn Circ J 65 965 968 1:STN:280:DC%2BD3MnntVansQ%3D%3D 10.1253/jcj.65.965 11716248 (Pubitemid 33035620)
11. JA Johnston CL Ward RR Kopito 1998 Aggresomes: a cellular response to misfolded proteins J Cell Biol 143 1883 1898 1:CAS:528:DyaK1MXisFCrtA%3D%3D 10.1083/jcb.143.7.1883 9864362 (Pubitemid 29022611)
12. J Lowe A Blanchard K Morrell G Lennox L Revnolds M Billett M Landon RJ Mayer 1988 Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease J Pathol 155 9 15 1:STN:280:DyaL1c3ksV2gsA%3D%3D 10.1002/path.1711550105 2837558
13. KS McNaught P Shashidharan DP Perl P Jenner CW Olanow 2002 Aggresome-related biogenesis of Lewy bodies Eur J Neurosci 16 2136 2148 10.1046/j.1460-9568.2002.02301.x 12473081 (Pubitemid 35454257)
14. RR Kopito 2000 Aggresomes, inclusion bodies and protein aggregation Trends Cell Biol 10 524 530 1:CAS:528:DC%2BD3cXot12ltL0%3D 10.1016/S0962- 8924(00)01852-3 11121744
15. PB Tran RJ Miller 1999 Aggregates in neurodegenerative disease: crows and power? Trends Neurosci 22 194 197 1:CAS:528:DyaK1MXivVOktbw%3D 10.1016/S0166-2236(99)01409-5 10322490 (Pubitemid 29202079)
16. J McMurray M Chopra I Abdullah WE Smith HJ Darqie 1993 Evidence of oxidative stress in chronic heart failure in humans Eur Heart J 14 1493 1498 1:STN:280:DyaK2c7jtVyqsA%3D%3D 8299631
17. M Keith A Geranmayegan MJ Sole R Kurian A Robinson AS Omran KN Jeejeebhoy 1998 Increased oxidative stress in patients with congestive heart failure J Am Coll Cardiol 31 1352 1356 1:STN:280:DyaK1c3ktVyltg%3D%3D 10.1016/S0735-1097(98) 00101-6 9581732 (Pubitemid 28219127)
18. Z Mallat I Philip M Lebret D Chatel J Maclouf A Tedqui 1998 Elevated levels of 8-iso-prostaglandin F2α in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure Circulation 97 1536 1539 1:STN:280:DyaK1c3lsVeruw%3D%3D 9593557
19. K Okada C Wangpoengtrakul T Osawa S Toyokuni K Tanaka K Uchida 1999 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules J Biol Chem 274 23787 23793 1:CAS:528:DyaK1MXlsVOnsLg%3D 10.1074/jbc.274.34.23787 10446139 (Pubitemid 29390301)
20. AL Bulteau KC Lundberg KM Humphries HA Sadek PA Szweda B Friquet LI Szweda 2001 Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion J Biol Chem 276 30057 30063 1:CAS:528: DC%2BD3MXmtFehsLk%3D 10.1074/jbc.M100142200 11375979
21. KS McNaught C Mytilineou R Jnobaptiste J Yabut P Shashidharan P Jennert CW Olanow 2002 Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures J Neurochem 81 301 306 1:CAS:528:DC%2BD38Xjt1Cjtrg%3D 10.1046/j.1471-4159.2002. 00821.x 12064477 (Pubitemid 34809355)
22. G Majno I Joris 1995 Apoptosis, oncosis and necrosis. An overview of cell death Am J Pathol 146 3 15 1:STN:280:DyaK2M7mtVWiug%3D%3D 7856735
23. J Narula N Haider R Virmani TG DiSalvo FD Kolodqie RJ Hajjar U Schmidt MJ Semigran GW Dec BA Khaw 1996 Apoptosis in myocytes in end-stage heart failure N Engl J Med 335 1182 1189 1:STN:280:DyaK28zpvFShtw%3D%3D 10.1056/ NEJM199610173351603 8815940 (Pubitemid 26339772)
24. Z Mallat A Tedgui F Fontaliran R Frank M Duriqon G Fontaine 1996 Evidence of apoptosis in arrhythmogenic right ventricular dysplasia N Engl J Med 335 1190 1196 1:STN:280:DyaK28zpvFShtA%3D%3D 10.1056/NEJM199610173351604 8815941 (Pubitemid 26339773)
25. ER McDonald 3rd WS El-Deiry 2004 Suppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growth Proc Natl Acad Sci USA 101 6170 6175 1:CAS:528:DC%2BD2cXjsFKnt7Y%3D 10.1073/pnas.0307459101 15069192 (Pubitemid 38520546)
26. SR Powell P Wang A Divald S Teichberg V Haridas TW McCloskey KJA Davies H Katzeff 2005 Aggregates of oxidized proteins (lipofuscin) induce apoptosis through proteasome inhibition and dysregulation of proapoptotic proteins Free Radic Biol Med 38 1093 1101 1:CAS:528:DC%2BD2MXisVCqs7o%3D 10.1016/j. freeradbiomed.2005.01.003 15780767 (Pubitemid 40386555)
27. P Tannous H Zhu A Nemchenko JM Berry JL Johnstone JM Shelton FJ Miller Jr BA Rothermel JA Hill 2008 Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy Circulation 117 3070 3078 1:CAS:528:DC%2BD1cXmvV2ltbk%3D 10.1161/CIRCULATIONAHA.107.763870 18541737
28. T Jung N Bader T Grune 2007 Lipofuscin. Formation, distribution, and metabolic consequences Ann N Y Acad Sci 1119 97 111 1:CAS:528: DC%2BD1cXpvVGitA%3D%3D 10.1196/annals.1404.008 18056959 (Pubitemid 350191226)
29. K Hasegawa H Fujiwara K Doyama M Mukoyama K Nakao T Fujiwara H Imura C Kawai 1993 Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. An immunohistochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodies Am J Pathol 142 107 116 1:STN:280:DyaK3s7kt1ygtw%3D%3D 8424448
30. TA McDonagh SD Robb DR Murdoch JJ Morton I Ford CE Morrison H Tunstall-Pedoe JJ McMurray HJ Dargie 1998 Biochemical detection of left-ventricular systolic dysfunction Lancet 351 9 13 1:STN:280: DyaK1c%2FpsFSjtQ%3D%3D 10.1016/S0140-6736(97)03034-1 9433422 (Pubitemid 28020159)
31. K Yamamoto JC Burnett Jr M Jougasaki RA Nishimura KR Bailey Y Saito K Nakao MM Redfield 1996 Superiority of brain natriuretic peptide as a hormonal maker of ventricular hypertrophy Hypertension 28 988 994 1:CAS:528: DyaK2sXisVSgtQ%3D%3D 8952587
32. T Tsutamoto A Wada K Maeda T Hisanaga Y Maeda D Fukai M Ohnishi Y Sugimoto M Kinoshita 1997 Attenuation of compensation of endogenous cardiac natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction Circulation 96 509 516 1:STN:280:DyaK2szos1eksg%3D%3D 9244219